Zhejiang Starry Pharmaceutical Co., Ltd

Form 483FOIA Uncovered

Taizhou, -FEI 3007027206Issued August 02, 2019

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3007027206.

ObservationsNot available

Issue DateAugust 02, 2019

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: Zhejiang Starry Pharmaceutical Co., Ltd
Location: Taizhou, -
FEI Number: 3007027206
Product Type: Drugs
Issue Date: August 02, 2019
Country: United States

Inspection History, 2019 to 2024

NAI1

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Zhejiang Starry Pharmaceutical Co., Ltd FDA Form 483, Taizhou, August 2, 2019